LPL Financial Welcomes Generational Asset Planning
SAN DIEGO, June 04, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Tre Panagos has joined […]
Quest Resource Holding Corporation Appoints Perry W. Moss to New Position as Chief Revenue Officer
THE COLONY, Texas, June 04, 2024 (GLOBE NEWSWIRE) — Quest Resource Holding Corporation (NASDAQ: QRHC) (“Quest”), a national leader in […]
Giant Eagle’s Leap Media Group Joins The Rippl Data & Media Network
ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) — Bridg, a division of Cardlytics, Inc. (NASDAQ: CDLX), today announced that Giant Eagle’s […]
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology […]
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
–Results in Performance of the Upper Limb (PUL 2.0) Continue to Show Benefits in Skeletal Muscle Function After 3 Years […]
YY Group Strengthens Board of Directors with Appointment of Three New Members
SINGAPORE, June 04, 2024 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”), a […]
Motorsport Games Unveils Exciting June Updates for Le Mans Ultimate and 2024 Content
MIAMI, June 04, 2024 (GLOBE NEWSWIRE) — Motorsport Games Inc. (NASDAQ: MSGM) is announcing a significant update to Le Mans […]
Advantage Solutions continues business simplification; sells content management platform The Data Council to SPINS
ST. LOUIS, June 04, 2024 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV), a leading business solutions provider to consumer […]
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
SALT LAKE CITY, June 04, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and […]
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for […]
